Literature DB >> 33947659

Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital.

Matthew Tanti1, Jeremy Cosgrove2, Charles Kelleher3, Rebekah Jones3, Melissa Maguire2.   

Abstract

BACKGROUND: Novel psychoactive substances (NPS) are a growing public health concern. We aimed to identify the acute neurological consequences of NPS.
METHOD: We performed a retrospective case-note review of patients who presented to the emergency department after taking NPS.
RESULTS: We identified 237 admissions from 190 patients, mostly young men. There were high rates of psychiatric comorbidity (43%), unemployment (39%), homelessness (24%) and incarceration (17%). Most reported use of synthetic cannabinoids (SC; 91%). Some took synthetic cathinones (SCath; 7%) or nitrous oxide (NOS; 2%). SC caused impaired consciousness (61%) and seizures (16%). SCath users presented with psychiatric disturbance or seizures (55%). Most patients were managed conservatively (67%) and a small proportion (14%) were referred to drug or psychology services.
CONCLUSIONS: NPS users represent a vulnerable group in society. Certain clinical features may suggest the type of NPS used. Most patients require supportive management and onward referral to drug addiction services is recommended. © Royal College of Physicians 2021. All rights reserved.

Entities:  

Keywords:  neurology; nitrous oxide; novel psychoactive substances; synthetic cannabinoids; synthetic cathinones

Mesh:

Substances:

Year:  2021        PMID: 33947659      PMCID: PMC8140705          DOI: 10.7861/clinmed.2020-0706

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  13 in total

1.  The increasing recreational use of nitrous oxide: history revisited.

Authors:  G Randhawa; A Bodenham
Journal:  Br J Anaesth       Date:  2015-08-30       Impact factor: 9.166

Review 2.  Novel psychoactive substances: types, mechanisms of action, and effects.

Authors:  Derek K Tracy; David M Wood; David Baumeister
Journal:  BMJ       Date:  2017-01-25

3.  Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change.

Authors:  P I Dargan; S Albert; D M Wood
Journal:  QJM       Date:  2010-07-30

4.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

5.  Ischemic stroke after use of the synthetic marijuana "spice".

Authors:  Melissa J Freeman; David Z Rose; Martin A Myers; Clifton L Gooch; Andrea C Bozeman; W Scott Burgin
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

6.  Use of novel psychoactive substances by inpatients on general adult psychiatric wards.

Authors:  Jack L Stanley; Daniel V Mogford; Rebecca J Lawrence; Stephen M Lawrie
Journal:  BMJ Open       Date:  2016-05-10       Impact factor: 2.692

7.  A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus-A case report and review of the literature.

Authors:  Marc-Alain Babi; Christopher P Robinson; Carolina B Maciel
Journal:  SAGE Open Med Case Rep       Date:  2017-12-05

Review 8.  The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review.

Authors:  Koby Cohen; Aviv Weinstein
Journal:  Brain Sci       Date:  2018-02-27

Review 9.  Potential Mechanisms Underlying the Deleterious Effects of Synthetic Cannabinoids Found in Spice/K2 Products.

Authors:  Balapal S Basavarajappa; Shivakumar Subbanna
Journal:  Brain Sci       Date:  2019-01-16

10.  Screening of new psychoactive substances (NPS) by gas-chromatography/time of flight mass spectrometry (GC/MS-TOF) and application to 63 cases of judicial seizure.

Authors:  Michele Dei Cas; Eleonora Casagni; Sebastiano Arnoldi; Veniero Gambaro; Gabriella Roda
Journal:  Forensic Sci Int       Date:  2019-04-14       Impact factor: 2.395

View more
  1 in total

1.  Novel psychoactive substance.

Authors:  Mark Pucci; Sally Bradberry; Loretta Ford
Journal:  Clin Med (Lond)       Date:  2021-07       Impact factor: 2.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.